JOSEPH W MORGAN
Allopathic & Osteopathic Physicians|Family Medicine BENTON, AR NPI 1861788028
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AR Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$9,797.44
- Category: General Payments
- Program years: PY2018–2024
- Record count: 702
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,620.99 across 78 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,620.99 | 78 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $503.93 | 2 |
| PFIZER INC. | $234.75 | 15 |
| GlaxoSmithKline, LLC. | $184.85 | 22 |
| Acerta Pharma LLC | $158.18 | 8 |
| Lilly USA, LLC | $56.48 | 4 |
| Astellas Pharma US Inc | $45.40 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.56 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.90 | 2 |
| Phathom Pharmaceuticals, Inc. | $32.27 | 2 |
| Novo Nordisk AS | $31.43 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.95 | 2 |
| ABBVIE INC. | $26.64 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.10 | 1 |
| ITI, Inc. | $22.63 | 1 |
| Abbott Laboratories | $21.77 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.95 | 1 |
| Axsome Therapeutics, Inc. | $19.09 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.51 | 1 |
| Mylan Specialty L.P. | $17.99 | 1 |
| DEXCOM, INC. | $17.89 | 1 |
| Exact Sciences Corporation | $16.47 | 1 |
| Antares Pharma, Inc. | $16.28 | 1 |
| Hologic Sales and Service, LLC | $14.73 | 1 |
| Merck Sharp & Dohme Corporation | $14.32 | 1 |
| Alkermes, Inc. | $13.92 | 1 |
By program year
Records — PY2024 (78)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.